RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
Cdk4
cyclin dependent kinase 4
IEP
associated with Multiple Endocrine Neoplasia Type 1;protein:increased expression:testes
RGD
PMID:18310289
RGD:2293582
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
IEP
associated with Multiple Endocrine Neoplasia Type 1;protein:decreased activity:testes
RGD
PMID:18310289
RGD:2293582
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Cga
glycoprotein hormones, alpha subunit
ISO
RGD
PMID:16007123
RGD:2293633
NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370
G
Esr1
estrogen receptor 1 (alpha)
ISO
protein:increased expression:testis
RGD
PMID:17656605
RGD:2290041
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Flt1
FMS-like tyrosine kinase 1
ISO
RGD
PMID:14517422
RGD:2301251
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Inha
inhibin alpha
ISO
RGD
PMID:11545298
RGD:2290379
NCBI chr 1:75,483,872...75,487,010
Ensembl chr 1:75,483,721...75,487,010
G
Lhb
luteinizing hormone beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25289773
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10580072 PMID:11857565 PMID:15967102 PMID:11857565
RGD:2302176 , RGD:2292537
NCBI chr17:89,023,812...89,099,487
Ensembl chr17:89,023,909...89,099,418
G
Pdgfa
platelet derived growth factor, alpha
ISO
protein:increased expression:testis, leydig cell
RGD
PMID:11994382
RGD:2298579
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
protein:increased expression:testis, leydig cell
RGD
PMID:11994382
RGD:2298579
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISO
mRNA:alternative form:testis protein:increased expression:testis, leydig cell
RGD
PMID:11920744 PMID:11994382
RGD:2298580 , RGD:2298579
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISO
protein:increased expression:testis, leydig cell
RGD
PMID:11994382
RGD:2298579
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Prl
prolactin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:4092719
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Prmt5
protein arginine N-methyltransferase 5
ISO
protein:altered localization
RGD
PMID:17437848
RGD:2299953
NCBI chr14:54,744,639...54,754,927
Ensembl chr14:54,744,644...54,754,982
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
ISO
ClinVar Annotator: match by term: Leydig cell adenoma, somatic, with male-limited precocious puberty
ClinVar
PMID:10580072 PMID:11857565
NCBI chr17:89,023,812...89,099,487
Ensembl chr17:89,023,909...89,099,418
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all